The melanoma clinical trials being conducted at Moffitt Cancer Center provide patients with novel opportunities to try exciting new treatments and be among the first to benefit from them. Through these important research studies, physicians are able to evaluate innovative treatment options and compare them with the current best practices. As a result, the standard of care, which is the best treatment currently available based on past research, improves continually for the benefit of all patients.
A patient’s eligibility for participating in melanoma clinical trials is carefully determined by considering several factors for each particular study. To ensure accuracy and help researchers achieve meaningful results, potential participants are screened based on characteristics like age, gender, type and stage of cancer, past treatments and overall health and wellness.
Once a patient qualifies for a clinical trial, he or she must then decide whether to participate. At Moffitt, we work carefully with our patients to make sure they have all the information they need to make informed choices. With regard to clinical trials for melanoma, our team will explain:
- What the study will entail and how it might affect the patient’s daily life
- How the proposed treatment compares with the standard of care
- The risks and benefits associated with the treatment under study
- Potential side effects
- The requirements of participation, including testing, hospitalization and physician visits
- Other available treatment options
- Whether long-term follow-up care will be needed
Moffitt is the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, and we continue to lead the way in cancer research. Our multispecialty team of melanoma experts works collaboratively to ensure that each patient receives highly individualized, supportive care, whether that includes a clinical trial or other advanced treatment option.
If you would like to learn about the melanoma clinical trials currently underway at Moffitt Cancer Center, you do not need a referral to consult with our cancer experts. Please call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online.